İnce Bağırsakta Gastrointestinal Stromal Tümör, Servikal Metastazı: Olgu Sunumu

Year 2008, Volume: 41 Issue: 1, 59 - 61, 01.04.2008

Vahide İşıl Uğur Taciser Demirkasımoğlu Ş. Pınar Kara Bülent Küçükplakçı Aytül Özgen Yeşim Elgin Cem Mısırlıoğlu Ergun Sanrı Tijen Yapıcı Nadi Özdamar

Abstract

Gastrointestinal (Gl) stromal tumors (GISTs) are the most common mesenchymal tumors specific to the Gl tract, generally defined as KIT (CD117)- positive tumors with a characteristic set of histologic features. These tumors, derived from Cajal cells or their precursors, most commonly occur at the age > 50 years in the stomach (60%), jejenum and ileum (30%), duodenum (4-5%), rectum (4%), colon and appendix (1-2%), and esophagus (< 1%), and rarely as apparent primary extragastrointestinal tumors in the vicinity of stomach or intestines. Their overall incidence has been estimated as 10 to 20 per million. The most frequent complications associated with GISTs are obstructions and hemorrhages. Surgical resection is the primary treatment of GISTs. Radiotherapy and chemotherapy are generally ineffective. Continuous postoperative follow-up is necessary, becouse most recurrences ocur within the fırst 2 years after complete surgical resection. Our case was a 63 years old male patient. He had an operation for an intestinal tumor in October 2003. The histological exa-mination revealed malignant gastrointestinal stromal tumor. He had no radiotherapy and chemotherapy. He had 4 years follovv-up without any problem. İn January 2007, he had a 3*3 cm right cervical mass. Cervical MRI showed a tumor on 5th cervical vertebra. He had a biopsy and its examination revealed gastrointestinal stromal tumor.

Keywords

Gastrointestinal stromal tumor, cervical metastases.

Gastrointestinal Stromal Tumor of the Intestine and Cen/ical Metastases: Case Report

Abstract

Gastrointestinal stromal tümörler (GIST), gastrointestinal sistemin en sık görülen mezenkimal tümörleridir. KİT (CD117)-pozitifliği ile birlikte diğer bazı histolojik özellikleri ile tanınırlar. En sık 50 yaşından sonra görülürler. Midede %60, jejenum ve İle-umda %30, duodenumda %4-5, rektumda %4, kolon ve apendikste %1-2, özefagusta %1'in altında görülür. Görülme sıklığı milyonda 10-20'dir. GIST'lerde en sık belirti obstrüksiyon veya kanamadır. GIST'lerde primer tedavi cerrahi rezeksiyondur. Radyoterapi ve kemo-terapi genellikle etkisizdir. Postoperatif dönemde takip gereklidir, çünkü komplet cerrahi rezeksiyon sonrasında rekürrenslerin çoğu ilk 2 yılda ortaya çıkar. Sunulan olgu 63 yaşında erkek hasta olup 2003 yılında ince bağırsak kökenli kitlesi öpere edildi. Postoperatif patoloji raporu malign GIST (jejenum) olarak geldi. Adjuvant radyoterapi veya kemoterapi uygulanmadı. Vakamız 4 yıl boyunca sorunsuz takip edildi. Hastamız Ocak 2007 yılında sağ boyunda 3*3 cm sert fikse kitle ile başvurdu, servikal MRI'da servikal 5. vertebra hizasında kitle saptandı. Biyopsi sonucu GIST olarak geldi.

Keywords

Gastrointestinal stromal tümör, GIST servikal metastaz.

References

• Mieltirıen M, Lasota J. Gastroinlestinal stromal tumors:
• Pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83.
• Hohenberger P. Gastrointestinal stromal tumors. Schweiz
• Rundsch Med Prax 2007;96:29-33.
• Wu Y, Zhu X, Ding Y. Diagnosis and treatment of gastroin­ testinal stromal tumors of the stomach: Report o f 28 cases. Ann d in Lab Sci 2007;37:15-21.
• Vukovic M, Moljevic N, Krivokuca D. A gastrointestinal stro­ m al tumor-case report. Med Pregl 2006;59:487-9.
• Wang M, Cao H, Ni XZ, et al. A clinicopathological study on 107 cases with gastrointestinal stromal tumors. Zhonghua Wei Chang Wai Ke Za Z hi 2007;10:39-42.
• Fernandez Salazar Ll, Alvarez Gago T, Sanz Rubiales A, Velayos Jimenez B, Aller de la Fuente R, Gonzalez Hernandez JM. Gastrointestinal stromal tumors (GISTs): Clinical aspeets. Rev Esp Enferm Dig 2007;99:19-24.
• Perez EA, Gutierrez JC, Jin X, et al. Surgical Outcomes of
• Gastrointestinal Sarcoma Including Gastrointestinal Stromal Tumors: A Popuiation-based Examination. J Gastrointest Surg 2007;11:114-25.
• Bertin M, Angriman I, Scarpa M, et al. Prognosis o f gastro­
• intestinal stromal tumors. Hepatogastroenterology 2007; 54:124-8.
• Tryggvason G, Kristmundsson T, Orvar K, Jonasson JG, Magnusson MK, Gislason HG. Clinical Study on Gastrointestinal Stromal Tumors (GIST) in Iceland, 1990- 2003. Dig Dis Sci, 2007:10.